Galileo Genomics Raises $16.5M in Private Financing | GenomeWeb

NEW YORK, Oct. 10 – Galileo Genomics, a Montreal-based developer of gene discovery technology, has raised $16.5 million in a round of private financing. 

Investissement Desjardins of Montreal was the lead investor, which other European venture capital firms, including BTF of the Netherlands and HBM BioVentures of Switzerland, also participated in the round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.